AlphaFold predicted structure
MAPKBP1 · O60336

Mean pLDDT
62.0/ 100
Low
1,514 residues
Confidence breakdown
- Very high(≥ 90)35%
- Confident(70–90)14%
- Low(50–70)4%
- Very low(< 50)47%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mitogen-activated protein kinase binding protein 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Cystic kidney disease
BIALLELIC, autosomal or pseudoautosomalRare multisystem ciliopathy disorders
BIALLELIC, autosomal or pseudoautosomalRenal ciliopathies
BIALLELIC, autosomal or pseudoautosomalTubulointerstitial kidney disease
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalDuctal plate malformation
BIALLELIC, autosomal or pseudoautosomalnephronophthisis 20
nephronophthisis
late-onset nephronophthisis
Juvenile nephronophthisis
neurodegenerative disease
nervous system benign neoplasm
atrial fibrillation
Abnormality of the skeletal system
hereditary disease
type 2 diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mitogen-activated protein kinase-binding protein 1
Negative regulator of NOD2 function. It down-regulates NOD2-induced processes such as activation of NF-kappa-B signaling, IL8 secretion and antibacterial response (PubMed:22700971). Involved in JNK signaling pathway (By similarity)
MAPKBP1 · O60336

Mean pLDDT
62.0/ 100
Low
1,514 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0